- Home
- GH vs OII Comparison
GH vs OII Comparison
Compare GH & OII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- OII
- Stock Information
- Founded
- GH 2011
- OII 1964
- Country
- GH United States
- OII United States
- Employees
- GH N/A
- OII N/A
- Industry
- GH Medical Specialities
- OII Oilfield Services/Equipment
- Sector
- GH Health Care
- OII Energy
- Exchange
- GH Nasdaq
- OII Nasdaq
- Market Cap
- GH 2.7B
- OII 2.8B
- IPO Year
- GH 2018
- OII N/A
- Fundamental
- Price
- GH $30.98
- OII $28.83
- Analyst Decision
- GH Strong Buy
- OII Buy
- Analyst Count
- GH 15
- OII 4
- Target Price
- GH $39.93
- OII $27.00
- AVG Volume (30 Days)
- GH 2.2M
- OII 768.7K
- Earning Date
- GH 11-06-2024
- OII 10-23-2024
- Dividend Yield
- GH N/A
- OII N/A
- EPS Growth
- GH N/A
- OII 76.07
- EPS
- GH N/A
- OII 1.32
- Revenue
- GH $692,256,000.00
- OII $2,602,340,000.00
- Revenue This Year
- GH $31.00
- OII $9.75
- Revenue Next Year
- GH $17.55
- OII $7.25
- P/E Ratio
- GH N/A
- OII $21.92
- Revenue Growth
- GH 29.20
- OII 12.84
- 52 Week Low
- GH $15.81
- OII $18.67
- 52 Week High
- GH $37.04
- OII $30.45
- Technical
- Relative Strength Index (RSI)
- GH 70.13
- OII 63.84
- Support Level
- GH $28.45
- OII $27.05
- Resistance Level
- GH $32.26
- OII $27.97
- Average True Range (ATR)
- GH 1.70
- OII 1.01
- MACD
- GH 0.39
- OII 0.11
- Stochastic Oscillator
- GH 75.19
- OII 91.67
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About OII Oceaneering International Inc.
Oceaneering International Inc is a global provider of engineered services and products robotic solutions to the offshore energy, defense, aerospace, manufacturing and entertainment industries. Most of Oceaneering's products are produced for the offshore oil and gas market. It had a 2020 segment realignment to promote synergies and cost efficiency. The five segments are subsea robotics; manufactured products; offshore projects group; integrity management and digital solutions; and aerospace and defense technologies. Within the segments are two businesses - services and products provided primarily to the oil and gas industry. The firm is also involved in the offshore renewables and mobility solutions industries.